<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756819</url>
  </required_header>
  <id_info>
    <org_study_id>Azilsmedox-5008</org_study_id>
    <secondary_id>MACS-2014-100663</secondary_id>
    <nct_id>NCT02756819</nct_id>
  </id_info>
  <brief_title>International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan</brief_title>
  <official_title>International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate antihypertensive effect of azilsartan medoxomil
      (Edarbi®) therapy on blood pressure in participants with overweight or obesity in routine
      clinical practice of hypertension (HTN) treatment in the Russian Federation and in the
      Republic of Kazakhstan..
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The drug being tested in this study is called azilsartan medoxomil. Azilsartan medoxomil is
      being tested to treat people who have hypertension. This study will look at the clinic
      systolic and diastolic blood pressure (SBP, DBP) in obese participants who will be prescribed
      with azilsartan medoxomil by physician.

      The study will enroll approximately 1916 patients. All participants will be asked to take
      azilsartan medoxomil as prescribed by their physician according to local SmPC.

      This multi-center trial will be conducted in the Russian Federation and the Republic of
      Kazakhstan. The overall duration of study for observation will be approximately 6 months.
      Participants will make multiple visits to the clinic as assigned by each physician according
      to their routine practice, in every 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 8, 2016</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Clinic Systolic Blood Pressure (SBP) at Month 6</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>The change in systolic blood pressure measured at visit 4 (month 6) relative to baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Clinic Diastolic Blood Pressure (DBP) at Month 6</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>The change in systolic blood pressure measured at visit 4 (month 6) relative to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Response</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>Response is defined as decrease of SBP ≥20 mm Hg or decrease of DBP ≥10 mm Hg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who Achieve Target Blood Pressure (BP) &lt;140 mm Hg</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>Target BP is defined as SBP &lt;140 mm Hg and DBP &lt;90 mm Hg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Clinic Systolic Blood Pressure (SBP) in Subgroups of Participants</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>Subgroups include participants who are overweight (body mass index [BMI] =25 to 30 kg/m^2), obese (BMI &gt;30 kg/m^2), have impaired glucose tolerance, metabolic syndrome and diabetes mellitus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Clinic Diastolic Blood Pressure (DBP) in Subgroups of Participants</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>Subgroups include participants who are overweight (body mass index [BMI] =25 to 30 kg/m^2), obese (BMI &gt;30 kg/m^2), have impaired glucose tolerance, metabolic syndrome and diabetes mellitus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve Target Blood Pressure (BP) in Subgroups of Participants</measure>
    <time_frame>Baseline and Month 6 (Visit 4)</time_frame>
    <description>Target BP is defined as SBP &lt;140 mm Hg and DBP &lt;90 mm Hg. Subgroups include participants who are overweight (body mass index [BMI] =25 to 30 kg/m^2), obese (BMI &gt;30 kg/m^2), have impaired glucose tolerance, metabolic syndrome and diabetes mellitus.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1956</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Azilsartan Medoxomil</arm_group_label>
    <description>Overweight or obese participants with hypertension who will receive azilsartan medoxomil tablets,orally, as prescribed by physician according to local summary of product characteristics (SmPC) will be observed for approximately 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azilsartan Medoxomil</intervention_name>
    <description>Azilsartan medoxomil tablets</description>
    <arm_group_label>Azilsartan Medoxomil</arm_group_label>
    <other_name>Edarbi</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight or obese participants with Hypertension grade 1-2 will be observed.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female participants ≥ 18 years of age with hypertension (HTN) 1-2 grade.

          2. Participants with:

               -  newly diagnosed arterial HTN or

               -  inadequately controlled previously prescribed monotherapy with
                  Renin-Angiotensin-Aldosterone System (RAAS) blocker or

               -  inadequately controlled previously prescribed combination therapy with RAAS
                  blocker + diuretic or RAAS blocker + calcium antagonist.

          3. The physician decides to prescribe Edarbi

               -  as monotherapy or

               -  as a part of combination therapy including diuretics or calcium antagonists;

          4. Overweight or obesity of any degree (body mass index&gt; 25 kg/m^2);

          5. Is capable of understanding the written informed consent, provides signed and written
             informed consent, and agrees to comply with protocol requirements. In case the
             participant is blind or unable to read, informed consent will also be witnessed.

        Exclusion Criteria:

          1. Confirmed secondary HTN;

          2. Contraindications for Edarbi of respective approved local summary of product
             characteristics (SmPC) of Edarbi;

          3. Any reasons of medical and non-medical character, which in the opinion of the
             physician can prevent participant participation in the study.

          4. Is an employee or family member of the investigator or study site personnel.

          5. Is currently participating in a clinical trial. Participation in non-interventional
             registries is permitted.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director Clinical Science</last_name>
    <role>Study Director</role>
    <affiliation>Takeda</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>JSC Central Clinical hospital</name>
      <address>
        <city>Almaty</city>
        <zip>050000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute of Cardiology and Internal Diseases</name>
      <address>
        <city>Almaty</city>
        <zip>050000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kazakh Medical University of Continuing Education</name>
      <address>
        <city>Almaty</city>
        <zip>050070</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Clinical Hospital</name>
      <address>
        <city>Almaty</city>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Scientific center of oncology and transpontology</name>
      <address>
        <city>Astana</city>
        <zip>10000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karaganda State Medical Academy</name>
      <address>
        <city>Karaganda</city>
        <zip>100012</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semipalatinsk State Medical Academy</name>
      <address>
        <city>Semey</city>
        <zip>71400</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altay regional cardiological center</name>
      <address>
        <city>Barnaul</city>
        <zip>656055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Belgorod Regional Clinical Hospital of St. Joasaph</name>
      <address>
        <city>Belgorod</city>
        <zip>308007</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryansk Regional Cardiological center</name>
      <address>
        <city>Bryansk</city>
        <zip>241050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical center Lotos</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454004</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional clinical Hospital #3</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istochnik Clinic</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454100</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center Academy of Health</name>
      <address>
        <city>Chita</city>
        <zip>672038</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chita State Medical Academy</name>
      <address>
        <city>Chita</city>
        <zip>672090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical AssociationNew Hospital</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620109</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Consultative Diagnostic center</name>
      <address>
        <city>Irkutsk</city>
        <zip>664047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiological center</name>
      <address>
        <city>Ivanovo</city>
        <zip>153012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultative Diagnostic Center Ministry of Health of Udmurt Republic</name>
      <address>
        <city>Izhevsk</city>
        <zip>426008</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City clinical hospital #2 sosnovaya roscha</name>
      <address>
        <city>Kaluga</city>
        <zip>248010</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kemerovo Regional Clinical Cardiological center named after Barabash L.S.</name>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kemerovo Regional Clinical hospital named after Belyaev S.V.</name>
      <address>
        <city>Kemerovo</city>
        <zip>650066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital #1 named after S.I.Sergeev</name>
      <address>
        <city>Khabarovsk</city>
        <zip>680009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Road clinical hospital at the station Khabarovsk JSC &quot;Russian Railways&quot;</name>
      <address>
        <city>Khabarovsk</city>
        <zip>680022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Clinical Emergency Hospital</name>
      <address>
        <city>Kirov</city>
        <zip>610011</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kirov Clinical hospital named after Yurlova V.I.</name>
      <address>
        <city>Kirov</city>
        <zip>610014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kostroma Regional Clinical Hospital named after Korolev E.I.</name>
      <address>
        <city>Kostroma</city>
        <zip>156013</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lipetsk City policlinic #7</name>
      <address>
        <city>Lipetsk</city>
        <zip>398036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC Medical center Semeynyiy doctor</name>
      <address>
        <city>Magnitogorsk</city>
        <zip>455034</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City policlinic #166, branch 1</name>
      <address>
        <city>Moscow</city>
        <zip>115304</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City policlinic #166, branch 2</name>
      <address>
        <city>Moscow</city>
        <zip>115516</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City clinical hospital #1 named after N.I. Pirogova</name>
      <address>
        <city>Moscow</city>
        <zip>117049</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #22</name>
      <address>
        <city>Moscow</city>
        <zip>117335</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #11,branch #1</name>
      <address>
        <city>Moscow</city>
        <zip>117393</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #11</name>
      <address>
        <city>Moscow</city>
        <zip>119331</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #11, branch #3</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Volga District Medical Centre (VDMC) under Federal Medical and Biological Agency (FMBA)</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Volga District Medical Centre (VDMC) under Federal Medical and Biological Agency (FMBA)</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603137</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omsk state medical university</name>
      <address>
        <city>Omsk</city>
        <zip>644099</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot;Novaya medicina&quot;</name>
      <address>
        <city>Orekhovo-Zuevo</city>
        <zip>142600</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penza Regional Clinical hospital named after N.N. Burdenko</name>
      <address>
        <city>Penza</city>
        <zip>440026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional clinical hospital named after N.N. Burdenko</name>
      <address>
        <city>Penza</city>
        <zip>440026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Cardiological Center</name>
      <address>
        <city>Perm</city>
        <zip>614002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Road Clinical Hospital at the Rostov-Ch. JSC Russian Railways</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344011</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rostov State Medical University</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Consultative Diagnostic Center #1</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #117</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>195299</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CJSC Cardioclinic</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>196105</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City Consultative Diagnostic Clinic#1 Primorsky District, Diabetological center #5</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197183</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #14</name>
      <address>
        <city>Samara</city>
        <zip>443011</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samara Regional Clinical Cardiological center</name>
      <address>
        <city>Samara</city>
        <zip>443070</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saratov city polyclinic #2</name>
      <address>
        <city>Saratov</city>
        <zip>410005</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LLC Multiprofile medical clinic Sova</name>
      <address>
        <city>Saratov</city>
        <zip>410056</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City polyclinic #3</name>
      <address>
        <city>Tomsk</city>
        <zip>634009</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Research Institute of Cardiology</name>
      <address>
        <city>Tomsk</city>
        <zip>634034</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tomsk Clinical hospital</name>
      <address>
        <city>Tomsk</city>
        <zip>634063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Cardiological center</name>
      <address>
        <city>Tver</city>
        <zip>170041</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tyumen Cardiological center</name>
      <address>
        <city>Tyumen</city>
        <zip>625000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cardiological center</name>
      <address>
        <city>Ulyanovsk</city>
        <zip>432012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City hospital #4</name>
      <address>
        <city>Vladimir</city>
        <zip>600020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Volgograd Regional Clinical hospital #1</name>
      <address>
        <city>Volgograd</city>
        <zip>400000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Volgograd Regional Clinical Cardiological center #1</name>
      <address>
        <city>Volgograd</city>
        <zip>400008</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Voronezh Regional Clinical Diagnostic center</name>
      <address>
        <city>Voronezh</city>
        <zip>394018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Voronezh City Clinical polyclinic #4</name>
      <address>
        <city>Voronezh</city>
        <zip>394077</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Medical Center</name>
      <address>
        <city>Yakutsk</city>
        <zip>677010</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yaroslavl Regional Clinical Hospital of War Veterans</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150047</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kazakhstan</country>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2016</study_first_submitted>
  <study_first_submitted_qc>April 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

